Amdocs Enterprise Value Over E B I T D A from 2010 to 2025

DOX Stock  USD 88.30  1.07  1.23%   
Amdocs Enterprise Value Over EBITDA yearly trend continues to be fairly stable with very little volatility. Enterprise Value Over EBITDA is likely to outpace its year average in 2025. During the period from 2010 to 2025, Amdocs Enterprise Value Over EBITDA regression line of annual values had r-squared of  0.06 and arithmetic mean of  13.36. View All Fundamentals
 
Enterprise Value Over EBITDA  
First Reported
2010-12-31
Previous Quarter
14.54
Current Value
15.35
Quarterly Volatility
8.23090616
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Amdocs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amdocs' main balance sheet or income statement drivers, such as Depreciation And Amortization of 183 M, Interest Expense of 42.1 M or Total Revenue of 3.2 B, as well as many indicators such as Price To Sales Ratio of 3.36, Dividend Yield of 0.0369 or PTB Ratio of 1.42. Amdocs financial statements analysis is a perfect complement when working with Amdocs Valuation or Volatility modules.
  
Check out the analysis of Amdocs Correlation against competitors.
For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.

Latest Amdocs' Enterprise Value Over E B I T D A Growth Pattern

Below is the plot of the Enterprise Value Over E B I T D A of Amdocs over the last few years. It is Amdocs' Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amdocs' overall financial position and show how it may be relating to other accounts over time.
Enterprise Value Over E B I T D A10 Years Trend
Pretty Stable
   Enterprise Value Over E B I T D A   
       Timeline  

Amdocs Enterprise Value Over E B I T D A Regression Statistics

Arithmetic Mean13.36
Geometric Mean12.15
Coefficient Of Variation61.63
Mean Deviation4.21
Median11.55
Standard Deviation8.23
Sample Variance67.75
Range35.2135
R-Value(0.24)
Mean Square Error68.30
R-Squared0.06
Significance0.36
Slope(0.42)
Total Sum of Squares1,016

Amdocs Enterprise Value Over E B I T D A History

2025 15.35
2024 14.54
2023 12.64
2022 11.96
2021 11.09
2020 9.38
2019 9.67

About Amdocs Financial Statements

Amdocs investors use historical fundamental indicators, such as Amdocs' Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Amdocs. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Enterprise Value Over EBITDA 14.54  15.35 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Amdocs Stock Analysis

When running Amdocs' price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.